Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ertapenem vs Ceftriaxone/Metronidazole in Intra-Abdominal Infections
NCT00481702Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2001
- Primary completion
- Jun 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ertapenem in Intra-abdominal infection (IAI), sponsored by Merck & Co.. Started Dec 2001; status: completed.
02
Drugs
ertapenem
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT00481702.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481702.